CORVAS INTERNATIONAL, INC.

Corvas International, Inc is develops biotherapeutics that address large medical markets, including cardiovascular disease and cancer.

#SimilarOrganizations #More

CORVAS INTERNATIONAL, INC.

Industry:
Biotechnology Health Care

Address:
San Diego, California, United States

Country:
United States

Status:
Active

Contact:
(858) 455-9800


Similar Organizations

cairn-biosciences-logo

Cairn Biosciences

Cairn Biosciences is developing next-generation therapeutics that address significant challenges in the treatment of serious diseases.

critical-diagnostics-logo

Critical Diagnostics

Critical Diagnostics is engaged in the R&D and commercialization of novel biomarkers in cardiovascular diseases.

nereus-pharmaceuticals-logo

Nereus Pharmaceuticals

Nereus Pharmaceuticals engages in the discovery and development of therapeutics for the treatment of infectious diseases and inflammation.

More informations about "Corvas International, Inc."

Corvas International - Products, Competitors, Financials, โ€ฆ

Jan 30, 1992 About Corvas International Developer of novel pharmaceuticals to prevent and manage thrombosis and related vascular diseases. These antithrombotic drugs will be used to โ€ฆSee details»

Corvas International Inc - Company Profile and News

Company profile page for Corvas International Inc including stock price, company news, executives, board members, and contact informationSee details»

Corvas International, Inc in 3030 Science Park Road, San Diego ...

Explore Corvas International, Inc profile. Get company overview, financials, FAQs, and similar companies for Corvas International, Inc, 3030 Science Park Road, San Diego, California, โ€ฆSee details»

Corvas International, Inc. - Crunchbase

Corvas International, Inc is develops biotherapeutics that address large medical markets, including cardiovascular disease and cancer.See details»

Corvas International, Inc. - Updates, News, Events ... - Crunchbase

Jul 30, 2003 Corvas International, Inc is develops biotherapeutics that address large medical markets, including cardiovascular disease and cancer.See details»

EIN 33-0238812 - Corvas International Inc, San Diego, California

Corvas International Inc is a corporation in San Diego, California. The employer identification number (EIN) for Corvas International Inc is 330238812. EIN for organizations is sometimes โ€ฆSee details»

Corvas International, Inc. - Drug pipelines, Patents, Clinical trials ...

Explore Corvas International, Inc. with its drug pipeline, therapeutic area, technology platform, 3 news, and 51 literature.See details»

Corvas 2025 Company Profile: Valuation, Investors, Acquisition

Corvas has raised $124M. Who are Corvasโ€™s investors? Allianz Technology Trust, Artisan Equity, Centocor, Gimv, and International Biotechnology Trust are 5 of 11 investors who have โ€ฆSee details»

CORVAS INTERNATIONAL INC (Form Type: SC 13G/A, Filing Date: โ€ฆ

Item 2 (b) Address of Principal Business Office: 100 E. Pratt Street, Baltimore, Maryland 21202 Item 2 (c) Citizenship or Place of Organization: (1) Maryland (2) Maryland Item 2 (d) Title of โ€ฆSee details»

Corvas International Inc โ€“ Filings and Transcripts โ€“ BamSEC

SEC filings and transcripts for Corvas International Inc, including financials, news, proxies, indentures, prospectuses, and credit agreements.See details»

CORVAS INTERNATIONAL INC Top 13F Holdings

Corvas International is based out of San Diego. Corvas International, Inc. is a biopharmaceutical company focused on the development of new biotherapeutics that address large medical โ€ฆSee details»

Corvas International Inc. - BioCentury Company Profiles - BCIQ

Corvas International Inc. - BioCentury Company Profiles for the biopharma industrySee details»

Corvas International - Crunchbase Company Profile & Funding

Corvus International provides companies with expertise in leadership, management, technical, and interpersonal development.See details»

Corvas International, Inc. (Corvas International, Inc.) - ่ฏ็‰ฉ็ฎก็บฟ_ไธ“ โ€ฆ

May 1, 2023 He has also served as program director of research and development at Sanofi Diagnostic Pasteur, vice president of research and development at Corvas International, Inc., โ€ฆSee details»

CORVAS INTERNATIONAL INC (Form Type: 10-Q/A, Filing Date: โ€ฆ

Corvas continues to receive R & D funding from Schering-Plough for the Factor Xa and Hepatitis C collaborations. Corvas International, Inc. is a biopharmaceutical company engaged in the โ€ฆSee details»

Corvas International - Company Profile - Tracxn

Feb 19, 2025 Corvas International - Recombinant proteins for the prevention of deep vein thrombosis (DVT), pulmonary embolism and unstable angina.. This company is not active โ€ฆSee details»

CORVAS INTERNATIONAL, INC. | SBIR.gov

THE GOAL OF THIS PROJECT IS TO DEVELOP A PROTHROMBIN TIME (PT) REAGENT USING PURIFIED, RECONSTITUTED RECOMBINANT HUMAN TISSUE FACTOR (RTF). โ€ฆSee details»

330238812 EIN/TAX ID | CORVAS INTERNATIONAL INC

An Employer Identification Number (EIN) is also known as a Federal Tax Identification Number, and is used to identify a business entity. Generally, businesses need an EIN. Business Name โ€ฆSee details»

Dendreon acquires Corvas International, Inc. - Crunchbase

Acquired Organization: Corvas International, Inc. Corvas International, Inc is develops biotherapeutics that address large medical markets, including cardiovascular disease and cancer.See details»

Jury delivers verdict finding Greenpeace entities liable for more โ€ฆ

4 days ago Free speech and right to protest on the line in the United States. Mandan, North Dakota โ€” A Morton County jury of nine reached a verdict in Energy Transferโ€™s meritless โ€ฆSee details»

linkstock.net © 2022. All rights reserved